SEC Filings | PTC Therapeutics, Inc.

Filing date	Description	Form	View
May 17, 2023	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	144	View HTML 0001959173-23-001157.pdf 0001959173-23-001157.xls
May 12, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001415889-23-007888.pdf 0001415889-23-007888.xls
May 11, 2023	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	144	View HTML 0001959173-23-001008.pdf
May 08, 2023	Notice of Exempt Offering of Securities	D	View HTML 0001567619-23-005926.pdf 0001567619-23-005926.xls
May 05, 2023	S-3ASR	S-3ASR	View HTML 0001104659-23-056578.pdf 0001104659-23-056578.xls
Apr 28, 2023	POSASR	POSASR	View HTML 0001104659-23-052977.pdf 0001104659-23-052977.xls
Apr 27, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001070081-23-000026.pdf 0001070081-23-000026.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 27, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001070081-23-000028.pdf 0001070081-23-000028.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 26, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	View HTML 0001070081-23-000020.pdf 0001070081-23-000020.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 26, 2023	Additional proxy soliciting materials - definitive	DEFA14A	View HTML 0001070081-23-000022.pdf 0001070081-23-000022.xls

Data provided by Kaleidoscope.